Three-Year Trial Finds MIND Diet No Better Than Standard Diet for Brain Health

A three-year randomised trial has delivered a sobering verdict on one of the most promoted eating patterns for brain health. Researchers comparing the MIND diet, which blends Mediterranean and DASH dietary principles and has been marketed as a way to reduce dementia risk, against a straightforward control diet found no meaningful difference in cognitive performance between the two groups.

What the trial tested

The study followed participants over 36 months, measuring changes in memory, executive function, and processing speed. Both groups received dietary counselling, but only one followed the MIND protocol's specific emphasis on leafy greens, berries, nuts, and whole grains. By the end of the trial, cognitive scores had moved in the same direction for both groups, suggesting that overall dietary quality mattered more than adherence to a branded pattern.

Omega-3 supplements under scrutiny

Separately, evidence reviewed alongside the trial indicated that omega-3 capsules produce no measurable cognitive benefit in healthy adults. While omega-3s remain important for cardiovascular health, the data do not support claims that popping a pill can sharpen memory or prevent age-related decline in people who are already well-nourished.

What this means for brain-food marketing

The findings do not contradict the broader link between nutrition and cognition. Instead, they reinforce a quieter truth: the evidence for specific "brain foods" builds slowly and is frequently outpaced by commercial enthusiasm.

• A balanced, vegetable-rich diet appears to support brain health, regardless of brand.
• Supplements rarely outperform whole-food sources for cognitive outcomes.
• Long-term lifestyle factors such as sleep, exercise, and social engagement remain the strongest levers.

For readers interested in related research, a recent study explored how a ten-hour eating window may aid memory and brain health in older adults, while another investigation examined the biological mechanisms identified in post-dieting weight regain. Separately, researchers have looked at how GLP-1 medications are emerging as a new challenge for the restaurant industry.